フォロー
Kei Sato
Kei Sato
Professor. Division of Systems Virology, The Institute of Medical Science, The University of Tokyo
確認したメール アドレス: g.ecc.u-tokyo.ac.jp - ホームページ
タイトル
引用先
引用先
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...
Nature 599 (7883), 114-119, 2021
12262021
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ...
Nature 603 (7902), 706-714, 2022
8582022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
R Suzuki, D Yamasoba, I Kimura, L Wang, M Kishimoto, J Ito, Y Morioka, ...
Nature 603 (7902), 700-705, 2022
5302022
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
A Saito, T Irie, R Suzuki, T Maemura, H Nasser, K Uriu, Y Kosugi, ...
Nature 602 (7896), 300-306, 2022
4912022
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
C Motozono, M Toyoda, J Zahradnik, A Saito, H Nasser, TS Tan, I Ngare, ...
Cell host & microbe 29 (7), 1124-1136. e11, 2021
4822021
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant
Y Konno, I Kimura, K Uriu, M Fukushi, T Irie, Y Koyanagi, D Sauter, ...
Cell reports 32 (12), 2020
4612020
Virological characteristics of the SARS-CoV-2 Omicron BA. 2 spike
D Yamasoba, I Kimura, H Nasser, Y Morioka, N Nao, J Ito, K Uriu, ...
Cell 185 (12), 2103-2115. e19, 2022
2532022
Virological characteristics of the SARS-CoV-2 Omicron BA. 2 subvariants, including BA. 4 and BA. 5
I Kimura, D Yamasoba, T Tamura, N Nao, T Suzuki, Y Oda, S Mitoma, J Ito, ...
Cell 185 (21), 3992-4007. e16, 2022
2192022
Neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine serum
K Uriu, I Kimura, K Shirakawa, A Takaori-Kondo, T Nakada, A Kaneda, ...
New England Journal of Medicine 385 (25), 2397-2399, 2021
2122021
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
D Yamasoba, Y Kosugi, I Kimura, S Fujita, K Uriu, J Ito, K Sato
The Lancet Infectious Diseases 22 (7), 942-943, 2022
1922022
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
I Kimura, Y Kosugi, J Wu, J Zahradnik, D Yamasoba, EP Butlertanaka, ...
Cell reports 38 (2), 2022
1902022
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
T Tamura, J Ito, K Uriu, J Zahradnik, I Kida, Y Anraku, H Nasser, M Shofa, ...
Nature communications 14 (1), 2800, 2023
1892023
Cell-to-cell infection by HIV contributes over half of virus infection
S Iwami, JS Takeuchi, S Nakaoka, F Mammano, F Clavel, H Inaba, ...
elife 4, e08150, 2015
1622015
SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion
IATM Ferreira, SA Kemp, R Datir, A Saito, B Meng, P Rakshit, ...
The Journal of infectious diseases 224 (6), 989-994, 2021
1512021
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
C Prelli Bozzo, R Nchioua, M Volcic, L Koepke, J Krüger, D Schütz, ...
Nature communications 12 (1), 4584, 2021
1512021
SARS-CoV-2 B. 1.617. 2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
P Mlcochova, S Kemp, MS Dhar, G Papa, B Meng, S Mishra, C Whittaker, ...
141*2021
Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins
K Sato, J Aoki, N Misawa, E Daikoku, K Sano, Y Tanaka, Y Koyanagi
Journal of Virology 82 (2), 1021-1033, 2008
1402008
Virological characteristics of the SARS-CoV-2 Omicron BA. 2.75 variant
A Saito, T Tamura, J Zahradnik, S Deguchi, K Tabata, Y Anraku, I Kimura, ...
Cell host & microbe 30 (11), 1540-1555. e15, 2022
1132022
A novel animal model of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in humanized mice
K Sato, N Misawa, C Nie, Y Satou, D Iwakiri, M Matsuoka, R Takahashi, ...
Blood, The Journal of the American Society of Hematology 117 (21), 5663-5673, 2011
1092011
Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility
T Kobayashi, H Ode, T Yoshida, K Sato, P Gee, SP Yamamoto, H Ebina, ...
Journal of virology 85 (2), 932-945, 2011
1062011
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20